ThermoGenesis Announces Management Transition; Provides Update on Operational ...(sposable for harvesting stem cells in a ...),Health

Date:12/3/2008

sposable for harvesting stem cells in a closed system. The AXP device is used for the processing of cord blood. GE Healthcare is the exclusive global distribution partner for the AXP cord blood product except for Central and South America, China and Russia/CIS, where ThermoGenesis markets through independent distributors. The MarrowXpress is used for isolating stem cells from bone marrow.

-- The CryoSeal(R) FS System, an automated device and companion sterile blood processing disposable, is used to prepare fibrin sealants from plasma in about an hour. The CryoSeal FS System is approved in the U.S. for liver resection surgeries. The CryoSeal FS System has received the CE-Mark which allows sales of the product throughout the European community. Asahi Medical is the exclusive distributor for the CryoSeal System in Japan and the Company markets through independent distributors in Europe and South America.

-- The Thrombin Processing Device(TM) (TPD(TM)) is a sterile blood processing disposable that prepares activated thrombin from a small aliquot of plasma in less than 30 minutes. The CE-Marked TPD is currently being marketed in Europe by Biomet, Inc., subsidiary Biomet Biologics, Medtronic, Inc. and independent distributors.

This press release contains forward-looking statements, and such statements involve risks and uncertainties that could cause actual outcomes to differ materially from those contemplated by the forward-looking statements. Several factors, including current financial market credit restrictions that impact our customers, exchange rate fluctuations on currency in countries where out customers do business, timing of FDA approvals, changes in customer forecasts, our failure to meet customers' purchase order and quality requirements, supply shortages, production delays, changes in the markets for customers' products, introduction timing and acceptance of our new products scheduled for f
'/>"/>

SOURCE ThermoGenesis Corp. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5
Related medicine news :

1. ThermoGenesis Reports First Quarter 2009 Results
2. ThermoGenesis Announces 10 New BioArchive(R) System Distributors
3. ThermoGenesis Announces Filing of 510(k) Application for MarrowXpress
4. Thermogenesis Announces New Initiative to Address Veterinary Regenerative Medicine
5. ThermoGenesis Corp. Reports First Quarter 2008 Results
6. ThermoGenesis Announces 510(k) Clearance for AutoXpress(TM) Cord Blood Processing System
7. Integrated Benefits Institute Announces Availability of 2007 IBI Benchmarking Data for Employers to Evaluate Effectiveness of their Health and Productivity Programs
8. Vertellus Specialties Announces Price Change
9. HLTH Corporation Announces Final Results of Its Tender Offer
10. Hill-Rom Announces First Quarter 2009 Dividend
11. Writing a Prescription for Safety: B. Braun CAPS(R) Announces New Advancements at ashp 2008